Guilin Jiqi is a pharmaceutical company listed on Shenzhen Stock Exchange from 1997. Taking into account the special institutional background of China, we thoroughly analyze possible motives for her accounting fraud in 2000. Guilin Jiqi made up the accounting profit in the semi-annual report. Interestingly, the employee shares of Guilin Jiqi began to be tradable in the open market from June. After rejecting other possibilities, we find that the most probable motive for this earnings manipulation is to help her employees, except top managers, to sell their shares at a huge profit. Our case evidence tells an interesting story regarding another form of insider trading. The management might recognize the contribution of employees by helping them to take advantage of investors fooled by inflated accounting profit. The pressure from subordinates possibly played an important role in the decision making of the management.